Free Trial
→ They're not telling you how bad this could get (From Parkview Capital Group) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVS Health Corporation stock logo
CVS
CVS Health
$87.79
+1.6%		$93.45
$69.51
▼
$110.68
$110.54B0.68.66 million shs8.47 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$414.52
+2.4%		$383.70
$328.57
▼
$603.88
$142.99B1.462.32 million shs1.90 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$258.25
+1.4%		$265.71
$184.66
▼
$281.07
$613.99B0.216.75 million shs5.39 million shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVS Health Corporation stock logo
CVS
CVS Health
+1.72%+2.32%-9.31%-14.51%+13.76%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
+2.41%+1.94%+13.04%+0.72%-5.99%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+1.33%-2.71%-6.13%-0.09%+36.67%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVS Health Corporation stock logo
CVS
CVS Health
$87.79
+1.6%		$93.45
$69.51
▼
$110.68
$110.54B0.68.66 million shs8.47 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$414.52
+2.4%		$383.70
$328.57
▼
$603.88
$142.99B1.462.32 million shs1.90 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$258.25
+1.4%		$265.71
$184.66
▼
$281.07
$613.99B0.216.75 million shs5.39 million shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVS Health Corporation stock logo
CVS
CVS Health
+1.72%+2.32%-9.31%-14.51%+13.76%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
+2.41%+1.94%+13.04%+0.72%-5.99%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+1.33%-2.71%-6.13%-0.09%+36.67%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CVS Health Corporation stock logo
CVS
CVS Health
2.96
Moderate Buy$107.2422.16% Upside
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.68
Moderate Buy$502.5321.23% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.80
Moderate Buy$276.226.96% Upside

Current Analyst Ratings Breakdown

Latest JNJ, ISRG, and CVS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/7/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Guggenheim logo
Guggenheim
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$287.00
10/6/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOverweight$485.00
10/6/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$287.00 ➝ $290.00
10/5/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$298.00 ➝ $303.00
10/1/2026
CVS Health Corporation stock logo
CVS
CVS Health
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight
9/29/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Bank of America Corporation logo
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral$278.00
9/29/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$270.00 ➝ $285.00
9/22/2026
CVS Health Corporation stock logo
CVS
CVS Health
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
9/22/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
9/11/2026
CVS Health Corporation stock logo
CVS
CVS Health
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight
9/10/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
HSBC Holdings plc logo
HSBC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$290.00 ➝ $320.00
(Data available from 10/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CVS Health Corporation stock logo
CVS
CVS Health
$402.07B0.28$15.14 per share5.80$59.38 per share1.48
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$10.06B14.55$9.50 per share43.63$50.52 per share8.21
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$94.19B6.61$14.31 per share18.05$33.85 per share7.63
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CVS Health Corporation stock logo
CVS
CVS Health
$1.77B$3.7823.2210.320.841.18%13.12%3.95%11/4/2026 (Estimated)
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.86B$8.7347.4841.373.0528.45%16.91%14.83%10/20/2026 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$26.80B$8.6329.9220.432.5021.48%32.42%13.35%10/13/2026 (Estimated)

Latest JNJ, ISRG, and CVS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2026Q3 2026
CVS Health Corporation stock logo
CVS
CVS Health
$1.65N/AN/AN/A$104.76 billionN/A
10/20/2026Q3 2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.64N/AN/AN/A$2.91 billionN/A
10/13/2026Q3 2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.69N/AN/AN/A$25.37 billionN/A
8/5/2026Q2 2026
CVS Health Corporation stock logo
CVS
CVS Health
$1.87$2.58+$0.71$2.31$100.03 billion$106.10 billion
7/16/2026Q2 2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.48$2.80+$0.32$2.29$2.83 billion$2.89 billion
7/15/2026Q2 2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.84$2.90+$0.06$2.27$25.06 billion$25.31 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
CVS Health Corporation stock logo
CVS
CVS Health
$2.663.03%+5.87%70.37%4 Years
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.362.08%+5.25%62.11%64 Years

Latest JNJ, ISRG, and CVS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/30/2026
CVS Health Corporation stock logo
CVS
CVS Health
quarterly$0.66503.1%10/22/202610/22/202611/2/2026
7/15/2026
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.341.96%8/25/20268/25/20269/8/2026
7/10/2026
CVS Health Corporation stock logo
CVS
CVS Health
quarterly$0.66502.49%7/23/20267/23/20268/3/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CVS Health Corporation stock logo
CVS
CVS Health
0.74
0.87
0.66
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
4.96
3.91
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.44
1.09
0.81

Institutional Ownership

CompanyInstitutional Ownership
CVS Health Corporation stock logo
CVS
CVS Health
80.66%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%

Insider Ownership

CompanyInsider Ownership
CVS Health Corporation stock logo
CVS
CVS Health
0.85%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.60%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
CompanyEmployeesShares OutstandingFree FloatOptionable
CVS Health Corporation stock logo
CVS
CVS Health
300,0001.28 billion1.27 billionOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
17,021353.28 million351.16 millionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,2002.41 billion2.41 billionOptionable

Recent News About These Companies

Amgen (AMGN) and Johnson & Johnson (JNJ) Catch Jim Cramer’s Eye for Different Reasons
 |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/amgen-amgn-johnson-johnson-jnj-034526795.html
Pfizer (PFE) Trades Below 10x Earnings. Why Does Johnson & Johnson (JNJ) Command More Than Twice the Multiple?
October 7 at 7:31 PM  |  insidermonkey.comhttps://www.insidermonkey.com/news/pfizer-pfe-trades-below-10x-earnings-why-does-johnson-johnson-jnj-command-more-than-twice-the-multiple-1849276/
Johnson & Johnson (NYSE:JNJ) Pricing Pact Eases Overhang Before Earnings
October 7 at 7:15 PM  |  kalkinemedia.comK
Pfizer (PFE) Trades Below 10x Earnings. Why Does Johnson & Johnson (JNJ) Command More Than Twice the Multiple?
October 7 at 7:15 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/pfizer-pfe-trades-below-10x-211941994.html
Johnson & Johnson (JNJ) Is Becoming a Growth Stock. Does AbbVie (ABBV) Make JNJ Look Expensive?
October 7 at 5:31 PM  |  insidermonkey.comhttps://www.insidermonkey.com/news/johnson-johnson-jnj-is-becoming-a-growth-stock-does-abbvie-abbv-make-jnj-look-expensive-1849275/
Johnson & Johnson (NYSE:JNJ) Stock Jumps 1.4% - Here's What Happened
October 7 at 5:19 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-johnson-johnson-nyse-jnj-stock-jumps-14-heres-what-happened-2026-10-07/
3 ‘Strong Buy’ Dividend Aristocrat Stocks on Analysts’ Watch List
October 7 at 5:11 PM  |  tipranks.comhttps://www.tipranks.com/news/3-strong-buy-dividend-aristocrats-on-analysts-watch-list?utm_source=marketbeat.com&utm_medium=referral
American National Bank & Trust Sells 4,125 Shares of Johnson & Johnson $JNJ
October 7 at 1:03 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-american-national-bank-trust-sells-4125-shares-of-johnson-johnson-jnj-2026-10-07/
24/7 Market News Highlights NeOnc, Revolution Medicines, Moderna, Merck, Johnson & Johnson and Genmab, AbbVie in 2026 Cancer Treatment Advances
October 7 at 9:51 AM  |  quiverquant.comQ
Johnson & Johnson Has Dividend Royalty Status. Does That Make It a Buy?
October 7 at 9:31 AM  |  247wallst.comhttps://247wallst.com/investing/2026/10/07/johnson-johnson-has-dividend-royalty-status-does-that-make-it-a-buy/
Johnson & Johnson Has Dividend Royalty Status. Does That Make It a Buy?
October 7 at 9:30 AM  |  247wallst.comhttps://247wallst.com/investing/2026/10/07/johnson-johnson-has-dividend-royalty-status-does-that-make-it-a-buy/?utm_source=snapi
Johnson & Johnson (NYSE:JNJ) Stock Rating Reaffirmed as Buy by Guggenheim
October 7 at 9:17 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-johnson-johnson-nyse-jnj-stock-rating-reaffirmed-as-buy-by-guggenheim-2026-10-07/
RBC Capital Keeps Their Buy Rating on Johnson & Johnson (JNJ)
October 7 at 9:15 AM  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/JNJ/pressreleases/5002288/rbc-capital-keeps-their-buy-rating-on-johnson-johnson-jnj/
Jim Cramer Has Soured on Intuitive Surgical (ISRG). The Reason is Johnson & Johnson
October 7 at 9:15 AM  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/jim-cramer-soured-intuitive-surgical-034319275.html
How ICOTYDE’s Long-Term Psoriasis Data At Johnson & Johnson (JNJ) Has Changed Its Investment Story
October 7 at 9:15 AM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/icotyde-long-term-psoriasis-data-071717308.html
The Crash-Proof Portfolio: 5 Elite Dividend Stocks Built to Survive a Market Meltdown
October 7 at 9:15 AM  |  247wallst.comhttps://247wallst.com/investing/2026/10/07/the-crash-proof-portfolio-5-elite-dividend-stocks-built-to-survive-a-market-meltdown/
The Crash-Proof Portfolio: 5 Elite Dividend Stocks Built to Survive a Market Meltdown
October 7 at 8:43 AM  |  247wallst.comhttps://247wallst.com/investing/2026/10/07/the-crash-proof-portfolio-5-elite-dividend-stocks-built-to-survive-a-market-meltdown/?utm_source=snapi
Financial Survey: Johnson & Johnson (NYSE:JNJ) and Rafael (NYSE:RFL)
October 7 at 5:28 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095602
Rep. Lloyd Doggett Purchases Shares of Johnson & Johnson (NYSE:JNJ)
October 7 at 2:30 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/congress-rep-lloyd-doggett-purchases-shares-of-johnson-johnson-nyse-jnj-2026-10-07/
Jim Cramer Has Soured on Intuitive Surgical (ISRG). The Reason is Johnson & Johnson
October 7 at 1:51 AM  |  insidermonkey.comhttps://www.insidermonkey.com/news/jim-cramer-has-soured-on-intuitive-surgical-isrg-the-reason-is-johnson-johnson-1850072/
Johnson & Johnson's Innovative Medicines Momentum Offsets MedTech Headwinds, RBC Capital Markets Says
October 6 at 1:43 PM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/johnson-johnson-apos-innovative-medicines-152114996.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Micron, Coherent and Tower Semiconductor: 3 Stocks Built on AI's Bottlenecks
NVIDIA Just Named AI's Next Bottleneck—And These 3 Stocks Sit Right In It
By Bridget Bennett | September 20, 2026
Desk setup showing a computer screen with a dividends bar chart and a printed dividend activity report.
The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
By Thomas Hughes | September 17, 2026
Three-panel composite showing a laboratory workbench, an open-plan office with desks, and a pharmacy with stocked medicine shelves.
3 Healthcare Stocks for 3 Stages of Life
By Jessica Mitacek | September 15, 2026
Laboratory workbench with chromatography instrument, pipettes, sample vials, and a notebook, with a production line visible beyond the glass wall.
3 Healthcare Dividend Stocks Offering More Than Just Income
By Chris Markoch | September 30, 2026
Desk setup with three monitors displaying a sector heat map, stock price charts, and market data above a city skyline view.
5 Defensive Stocks to Watch as CPI and the Fed Put the Rally to the Test
By Ryan Hasson | September 8, 2026
CVS Health stock logo

CVS Health NYSE:CVS

$87.79 +1.36 (+1.57%)
Closing price 10/7/2026 03:58 PM Eastern
Extended Trading
$88.15 +0.36 (+0.41%)
As of 10/7/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$414.52 +9.76 (+2.41%)
Closing price 10/7/2026 04:00 PM Eastern
Extended Trading
$415.00 +0.48 (+0.12%)
As of 10/7/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$258.25 +3.47 (+1.36%)
Closing price 10/7/2026 03:58 PM Eastern
Extended Trading
$258.75 +0.50 (+0.20%)
As of 10/7/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas